The PI3K/Akt/mTOR signaling pathway, which plays a significant role in tumor progression, has also been implicated in promoting glycolysis in HCC cells by regulating GLUT4 and HK2 (28, 29). Here, MTOR is linked to hepatocellular carcinoma.